Non-invasive diabetes therapies are becoming popular with patients suffering from type 2 diabetes. These include diet control, glucose monitoring, and insulin administration. The most common form of non-invasive diabetes therapy is lifestyle modification, which means that the patient attempts to improve his or her dietary habits by making appropriate modifications in diet and physical activity. This type of treatment is more useful for long-term diabetes management, as it helps maintain a healthy weight and blood sugar level throughout the patient’s lifetime. The most common form of non-invasive diabetes therapy is lifestyle modification, which means that the patient attempts to improve his or her dietary habits by making appropriate modifications in diet and physical activity. This type of treatment is more useful for long-term diabetes management, as it helps maintain a healthy weight and blood sugar level throughout the patient’s lifetime.
For Requesting a Sample Copy of This Report, Please Visit @
Increasing prevalence of diabetes is expected to drive growth of the global non-invasive diabetes therapy market during the forecast period. According to the World Health Organization (WHO), the number of people with diabetes has increased from 108 million in 1980 to 422 million in 2014. According to the same source, in 2016, around 1.6 million deaths were directly caused due to diabetes. This, in turn, has increased the preference for non-invasive treatment options. Non-invasive devices can measure blood glucose for diabetes with no need to poke the skin and draw blood.
However, the high costs associated with diabetes management devices and lack of adherence of patients to recommended treatment guidelines are expected to hinder the global non-invasive diabetes therapy market growth over the forecast period.
Impact of COVID-19 Pandemic
The outbreak of the COVID-19 pandemic has impacted numerous industries and markets including the global non-invasive diabetes therapy market. Following the outbreak in December 2019, many countries decided to close their borders and suspend international travel temporarily. Stringent regulations on physical distancing were implemented, which lead to disruption in manufacturing activities. Besides, the global supply chain industry witnessed a major negative impact due to nationwide lockdown policies, which subsequently hindered the global non-invasive diabetes therapy market significantly. However, the rollout of vaccines and declining cases is expected to aid the market in recovering gradually.
Request a PDF Brochure with Latest Insights @
The global non-invasive diabetes therapy market is expected to witness significant growth, exhibiting a CAGR of XX% during the forecast period. This is owing to favorable national health strategies and awareness campaigns. For instance, in October 2021, BeatO, an Indian digital care platform, launched a nationwide diabetes awareness program ‘India Beats Diabetes’ to encourage people to adopt a healthier lifestyles.
Among regions, North America is expected to gain significant traction in the global non-invasive diabetes therapy market over the forecast period. This is owing to high expenditure on R&D activities and the presence of key companies in the region.
Asia Pacific is expected to witness significant growth in the global non-invasive diabetes therapy market. This is owing to a sharp increase in diabetes cases across the region. According to the National Diabetes and Diabetic Retinopathy Survey, in 2019, there is around 11.8% prevalence of diabetes in India.
Key companies involved in the global non-invasive diabetes therapy market are Bio Tex, Calisto Medical, DexCom, Bayer, ACON Laboratories, and B. Braun Melsungen.
Reasons to Purchase this Report
• Current and future of global Non Invasive Diabetes Therapy market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
Global Non Invasive Diabetes Therapy Market Research Report
Section 1: Global Non Invasive Diabetes Therapy Industry Overview
Section 2: Global Economic Impact on Non Invasive Diabetes Therapy Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Non Invasive Diabetes Therapy Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy, and Downstream Buyers
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027